Xconomy Boston

Business Development Boston Conference—SOLD OUT

04/08/08
8:00 a.m.-12:30 p.m.
Charles Hotel, One Bennett St., Cambridge

The Business Development Boston Conference, a forum and networking opportunity for pharmaceutical and biotech business development leaders, is returning for its second year. The powerhouse list of hosts includes top executives of RA Capital, Genzyme, Endo Pharmaceuticals, Pfizer, Hoffmann-La Roche, GlaxoSmithKline, Infinity Pharmaceuticals, Vertex, Sirtris Pharmaceuticals, and Biogen Idec.

Individual panels are dedicated to Pharma, VC/Investor, and Biotech. Keynoting is Edmund P. Harrigan, SVP, Worldwide Business Development, for Pfizer.

Update, April 4 — This event is now sold out.

Bob is Xconomy's founder and editor in chief. You can e-mail him at bbuderi@xconomy.com, call him at 617.500.5926, or follow him on Twitter at http://twitter.com/bbuderi.

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.